CD274 and hepatocellular carcinoma: The C-C motif chemokine receptor 4 inhibitor C-021 or the TGF-βR I inhibitor galunisertib, when combined with anti-PD-L1 therapy, has been found to suppress SOX12-mediated HCC progression and metastasis (131).